Skip to Main Content

Advertisement

Skip Nav Destination

Issues

TOP READS

J Immunol (2024) 212 (5): 751.

LETTERS TO THE EDITOR

J Immunol (2024) 212 (5): 753.

BRIEF REVIEWS

J Immunol (2024) 212 (5): 755–763.

CUTTING EDGE

J Immunol (2024) 212 (5): 765–770.

  • M.tb induces AIM2 expression in a PPARγ-dependent and M.tb ESX-1–independent manner.

  • PPARγ, not AIM2, is important for M.tb-induced IL-1β release in human macrophages.

  • NLRP3 colocalizes with M.tb and is important for IL-1β release in human macrophages.

ALLERGY AND OTHER HYPERSENSITIVITIES

J Immunol (2024) 212 (5): 771–784.

  • SCFAs suppress IgE-mediated activation of mast cells in vivo and in vitro.

  • GPR109A, PGE2, EP3, and HDACi are involved in antiallergic effects of SCFAs.

CLINICAL AND HUMAN IMMUNOLOGY

J Immunol (2024) 212 (5): 785–800.

  • Elevation in NMOSD and MG CD56dimCD16dim/− NK cells suggests prior ADCC activity.

  • CD56dimCD16dim/− NK cells exhibit HLA-DR, trogocytosis, and reduced cytotoxicity.

  • MOGAD NK cells do not exhibit functional, phenotypic, or transcriptional changes.

IMMUNE REGULATION

J Immunol (2024) 212 (5): 801–812.

  • USP13 promotes SCRV replication by inhibiting IFN responses.

  • USP13 promotes the autophagic degradation of MAVS.

  • USP13 recruits MARCH8 to catalyze MAVS for autophagic degradation.

IMMUNOGENETICS

J Immunol (2024) 212 (5): 813–824.

  • Cmv5s, comprising multiple MHC loci, dominantly impedes NK cell MCMV control.

  • Cmv5s NK cells selectively display high Tim-3 and Lag-3 during MCMV infection.

  • Cmv5s splenic tissue damage precedes divergence in viral load and NK cell phenotype.

IMMUNOTHERAPY AND VACCINES

J Immunol (2024) 212 (5): 825–833.

  • SARS-CoV-2–specific CD8+ T cells are frequently detected in convalescent donors.

  • Allogeneic plasmacytoid cell line expands specific SARS-CoV-2 CD8+ T cells in vitro.

  • TCR sequencing for two T cell clones that target highly immunogenic epitopes.

INFECTIOUS DISEASE AND HOST RESPONSE

J Immunol (2024) 212 (5): 834–843.

  • Neonatal and adult CD8+ T cells adopt different fates during chronic infection.

  • Neonatal CD8+ T cells retain their effector bias and limit early viral replication.

  • Adult CD8+ T cells preferentially become exhausted and are less protective.

INNATE IMMUNITY AND INFLAMMATION

J Immunol (2024) 212 (5): 844–854.

  • Reduced miR-345-3p levels boost inflammation in a rat IAFF model.

  • miR-345-3p deletion hinders macrophage polarization.

  • miR-345-3p inhibits MAP3K1/NF-κB, aiding M1 to M2 macrophage shift.

J Immunol (2024) 212 (5): 855–867.

  • TLR5M and TLR5S synergistically sense flagellin in the early endosome in lamprey.

  • N-glycosylation N239 switches the ligand-binding and immune response for TLR5M/TLR5S.

  • TLR5M and TLR5S contain complex-type N-glycan, but only the high-mannose type for TLR5M.

J Immunol (2024) 212 (5): 868–880.

  • The KIR2DS1 and KIR2DL1-C245 receptors dominantly repress NK cell ADCC.

  • Education by inhibitory KIR does not enhance the ADCC capacity of NK cells.

  • NKG2A expression on NK cells consistently associates with superior ADCC.

J Immunol (2024) 212 (5): 881–893.

  • Alcohol combined with burn injury decreases miR-146a in small intestinal epithelial cells.

  • Reduced miR-146a promotes intestinal inflammation after alcohol and burn injury.

SYSTEMS IMMUNOLOGY

J Immunol (2024) 212 (5): 894–903.

  • Antileishmanials modulate transcriptomic profiles of inflammation and skin remodeling.

  • Sustained inflammation and impaired tissue remodeling lead to CL treatment failure.

  • Major transcriptional changes in CL lesions occur at 10 days of treatment.

J Immunol (2024) 212 (5): 904–916.

  • A predictive model of vaccine reactogenicity using in vitro assay data is presented.

  • A subset of tested biomarkers had higher predictive importance for adverse event risk.

TUMOR IMMUNOLOGY

J Immunol (2024) 212 (5): 917–927.

  • FMR1NB is a (to our knowledge) novel target for CAR against lung cancer.

  • 2DG makes T cells resistant to immune-inhibitory molecules.

  • 2DG-treated T cells augment anti–lung cancer cytotoxicity of anti-FMR1NB CAR.

EXPRESSIONS OF CONCERN

J Immunol (2024) 212 (5): 928.
Close Modal

or Create an Account

Close Modal
Close Modal